Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elewaut, D
Right arrow Articles by Müller-Ladner, U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elewaut, D
Right arrow Articles by Müller-Ladner, U
Annals of the Rheumatic Diseases 2003;62:789-790
© 2003 by BMJ Publishing Group & European League Against Rheumatism


EULAR news

Getting scientists together: the ACR/EULAR exchange programme

D Elewaut 1, M Aringer 2, U Müller-Ladner 3

1 Department of Rheumatology, University Hospital Gent, Belgium
2 Department of Rheumatology, Internal Medicine III, University of Vienna, Austria
3 University of Regensburg, Regensburg, Department of Internal Medicine I, Germany

Correspondence to:
Correspondence to:
Professor D Elewaut, Department of Rheumatology, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium;
dirk.elewaut@rug.ac.be

Keywords: ACR; EULAR exchange

The first 150 words of the full text of this article appear below.

Many of the landmark discoveries in biomedical science were based on individual brilliance and talent. However, over the years it became apparent that the pathogenesis of various diseases, and of autoimmune disorders in particular, is complex and requires a multidisciplinary approach. For example, the search for disease susceptibility genes in human diseases demands intensive collaboration between clinicians, geneticists, molecular biologists, and biostatisticians. Furthermore, the technological revolution in the field of biomedical research requires international collaboration to exchange the necessary expertise. International meetings, although very useful for the scientific community, have their limitations. By their nature, such meetings can increase subspecialisation and in overview sessions the large numbers of participants may be counterproductive for personal contact. This can be a particular barrier to younger members of the scientific community who wish to get involved with other groups. However, it will fall to these young scientists to strengthen the network to target . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & European League Against Rheumatism